Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7360 p129
30 July 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Audit Scotland: A Scottish prescription: managing the use of medicines in hospitals
   Main report PDF (1.7 MB)
   Key findings PDF (600K)


Pharmacy should be represented at senior levels

NHS boards should ensure that pharmacy is represented at senior levels of decision-making, according to a report published by Audit Scotland this week.

The report entitled “A Scottish prescription: managing the use of medicines in hospitals” (PDF 1.7 MB) is the result of a review of the 12 mainland NHS boards, including 15 NHS bodies. It says that in order to plan effectively, and ensure that patients get access to the best medicines to meet their clinical needs, NHS boards need an up-to-date understanding and awareness of the wide range of issues that contribute to best practice in the use of medicines. “Pharmacy managers have that overview but most are not represented on key decision-making groups, such as senior management teams at NHS boards and operating divisions,” it states.

The report also recommends that the Scottish Executive Health Department should improve workforce planning for pharmacists and pharmacy technicians. “The SEHD and NHS boards should ensure that workforce planning includes preregistration [trainee] posts and that sufficient training posts are available to meet the future needs of the service,” the report says. It recommends that meaningful measures of activity for pharmacy staffing are developed in order to inform workforce planning.

The expanding and valuable role of clinical pharmacists is acknowledged in the report. However it says that only two-thirds of hospitals have a clinical pharmacy service and recommends that NHS boards develop plans to address gaps in this service.

A further recommendation is that a national hospital electronic prescribing and medicines administration system should be implemented to provide SEHD and NHS boards with better information on how medicines are used.

Norman Lannigan, chief pharmacist, NHS Lothian University Hospitals Division, and a member of the review advisory group, told The Journal: “This report, which will be presented to the Scottish Parliament, raises awareness of clinical and financial risk associated with the use of medicines in hospitals. It recognises the unique and leading contribution of pharmacy in managing these risks and it is particularly welcome that one of the recommendations is that pharmacy should be represented at the highest levels in NHS organisations.

“A challenge for the NHS in Scotland will be to address the variation in availability of clinical pharmacy services. Highlighted are the developing roles, such as supplementary prescribing and ward-based pharmacy technicians, which are seen by the report as being of good value and of benefit to good patient care as well as the effective management of risks associated with the use of medicines.”

Back to Top


©The Pharmaceutical Journal